- Open Access
Schistosoma japonicum infection causes a reprogramming of glycolipid metabolism in the liver
Parasites & Vectorsvolume 12, Article number: 388 (2019)
Recent investigations indicate that schistosome infection is closely associated with aberrant glycolipid metabolism. However, the actual glycolipid metabolism gene expression, as well as the possible pathways that regulate glycolipid metabolism in the schistosome-infected liver, has not been extensively explored.
In this study, we evaluated the dynamic expression of glycolipid metabolism-associated genes and proteins in the livers from mice infected with Schistosoma japonicum at the indicated time points using real-time PCR and immunofluorescence. Then, cultures of macrophages were treated with schistosome soluble egg antigen (SEA) to detect the expression levels of genes associated with glucose and lipid metabolism in order to identify macrophages metabolic characteristics in response to these antigens. Furthermore, SEA-stimulated macrophages were co-cultures with hepatocytes and detected the effects of macrophages on the gene expression of hepatocytes metabolism.
The expression of glycolysis-related genes (Ldha, Glut4, Pkm2, Glut1, Pfkfb3, Aldoc, HK2, Pfk) in the liver were upregulated but the gluconeogenesis gene (G6pc) was downregulated during S. japonicum infection. In addition, the mRNA levels of fatty acid (FA) oxidation-related genes (Ucp2, Atp5b, Pparg) in the liver were significantly upregulated; however, the FA synthesis genes (Fas, Acc, Scd1, Srebp1c) and lipid uptake gene (Cd36) were downregulated post-S. japonicum-infection. In consistence with these data, stimulation with SEA in vitro significantly enhanced the gene expression that involved in glycolysis and FA oxidation, but decreased genes related to gluconeogenesis, FA synthesis and lipid uptake in macrophages. The levels of phosphorylated AMPK, AKT and mTORC1 were increased in macrophages after SEA stimulation. Inhibition of phosphorylated AMPK, AKT and mTORC1 promoted SEA-treated macrophages to produce glucose. In addition, suppression of phosphorylated-AMPK, but not phosphorylated-AKT and phosphorylated-mTOR, induced the lipid accumulation in SEA-stimulated macrophages. Furthermore, SEA-treated macrophages significantly reduced the expression of Acc mRNA in hepatocytes in vitro.
These findings reveal S. japonicum infection induces dynamic changes in the expression levels of genes involved in catabolism (glucose uptake, glycolysis and fatty acid oxidation) and suppressing anabolism (glycogen synthesis) in the liver, which could occur via macrophages’ metabolic states, particularly those involved in the AMPK, AKT and mTORC1 pathways.
Recently, increasing attention has focused on the inverse association between schistosome infection, the most chronic helminth infections in humans in nature, and metabolism-related diseases, including obesity and diabetes [1, 2]. Recently, several studies have suggested that specific immune responses, such as anti-inflammatory response, eosinophilia and M2 polarization, might contribute at least partly to this issue [3,4,5]. Importantly, our previous study indicated that chronic S. japonicum infection or SEA treatment in the mouse model can regulate host metabolic homeostasis through promoting Th2 responses in the liver . However, the potential mechanism that regulates the glucose and lipids metabolism of the liver during S. japonicum infection remains unclear.
The liver, a main metabolic organ of the body, plays major metabolic roles in regulating the homeostasis of glucose and lipids, as well as amino acids during alterations of metabolic conditions . As one of the major cellular constituents and important immune regulators of liver pathology in schistosomiasis [7,8,9], macrophages have been reported to play critical roles in maintaining hepatic informatory and metabolic homeostasis. In response to environmental signals, macrophages undergo polarized activation to classically activated macrophages (M1) or alternatively activated macrophages (M2)-like activation states. The M1 macrophages exhibit a high level of arginine metabolism and maintain the glycolytic activity by enhancing the expression of the pro-glycolytic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3); M2 macrophages shift macrophage metabolism into fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS) states, directed by signaling via IL-4 . It has been proposed that during weight gain macrophages undergo a “switch” from an anti-inflammatory M2 to a pro-inflammatory M1 state, that may contribute to systemic insulin resistance, the anti-inflammatory cytokine IL-10, which is produced from M2 macrophages, protects adipocytes from TNF-α-induced insulin resistance . Interestingly, injections with S. mansoni-soluble egg antigens (SEA) improved peripheral glucose uptake and high-fat-diet-induced insulin resistance and obesity, which was associated with the increased adipose tissue M2 macrophages . PF4178903, dual CCR2/CCR5 antagonism, has been reported to limit the adipocyte size and inhibit body weight through inducing a shift into the M2-dominant phenotype . Therefore, it is suggested that maintaining the balance of macrophage metabolic homeostasis may be a potential therapeutic strategy for metabolic diseases.
The dynamics of liver metabolism during schistosome infection have not yet been investigated. In addition, the possible effects of schistosomal egg antigens on macrophages metabolism are still unknown. Our study systematically investigated the kinetics of the gene expression related to hepatic glycolipid metabolism in experimentally S. japonicum-infected mice and examined the potential effects of schistosomal egg antigens on the macrophage metabolism, which provide a better understanding of the mechanisms by which helminth infection regulates host metabolic homeostasis.
Six-week-old female C57BL/6 mice purchased from the Animal Core Facility of Nanjing Medical University were bred under specific-pathogen-free (SPF) conditions.
Schistosoma japonicum infection and preparation of antigen
Each mouse was infected with 12 cercariae of S. japonicum. Six mice were randomly chosen from the infected and normal control groups at 0, 4, 7 and 11 weeks post-infection in each independent experiment, and all the mice were euthanized via diethyl ether-induced anesthesia for further study.
Schistosome egg antigen (SEA) was obtained from Jiangsu Institute of Parasitic Diseases, Wuxi, China, and prepared following a previously described method with some modifications . Briefly, rabbits were infected by ~ 2000 cercariae, and their livers were collected and cut into a number of pieces six to seven weeks post-infection. Then, the liver pieces were homogenized in PBS on ice and then filtered, washed and centrifuged. Purified eggs in pre-cooled PBS were sonicated three times for 15 min. The suspension was frozen/thawed several times and centrifuged at 25,000×g for 30 min. A 0.22-μm filter was used to pass the supernatant and obtain SEA, which was evaluated for contaminating endotoxin (LPS) by the chromogenic LAL end-point assay kit (Cambrex, Charles City, IO, USA). The concentration of LPS in SEA was below 1.2 endotoxin units (EU)/mg. A bicinchoninic acid (BCA) Protein Assay kit (Bio-Rad, Richmond, CA, USA) was used to determine the protein concentration.
Fasting blood glucose detection
Blood was collected from the tail of fasting control and S. japonicum-infected mice (from 6:00 to 10:00 h), and then the fasting blood glucose (FBG) was measured using a hand-held glucometer (Bayer Breeze 2; Bayer Inc., Toronto, ON, Canada).
Cell lines and in vitro treatment
RAW264.7 cells were purchased from the Cell Bank of Chinese Academy of Sciences. RAW264.7 cells were cultured on plastic aseptic dishes in DMEM, supplemented with 10% FBS, and penicillin (100 IU/ml)/streptomycin (100 mg/ml). Cells were maintained at 37 °C, 5% CO2 in a humidified atmosphere.
For antigen treatment, PBS (control) or 20 μg/ml SEA were added directly to each well and then incubated for 24 h at 37 °C.
RNA from liver tissue and cells was extracted with a RNeasy Mini Kit (Qiagen, Hilden, Germany). Then, RNA was reverse-transcribed by using a RevertAid™ First Strand cDNA Synthesis Kit (Fermantas Life Sciences, St. Leon-Rot, Baden-Württemberg, Germany). Real-time PCR was performed using Power Syber Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The housekeeping gene β-actin was used to normalize the gene expression by using the 2−ΔΔCt method. All primer sequences are shown in Additional file 1: Table S1.
An equal amount of protein (~ 30 μg) in each group was electrophoresed by SDS-PAGE and were then was then blotted onto nitrocellulose. Then, the membranes were blocked in 5% milk for 2 h, washed and incubated with primary antibodies: rabbit anti-phospho-ACC (Abcam, Cambridge, MA, USA), rabbit anti-ACC (Abcam), rabbit anti-phospho-AKT (Bioworld Technology, Louis Park, MN, USA), rabbit anti-AKT (Bioworld), rabbit anti-phospho-AMPKɑ (Cell Signaling Technology, Beverly, MA, USA), rabbit anti-AMPKɑ (D5A2) (Cell Signaling Technology), anti-phospho-mTORC1 (Bioworld), rabbit anti-mTORC1(S2442) (Bioworld), rabbit anti-phospho-PI3K (Bioworld), rabbit anti-PI3K P85α (Bioworld), or rabbit anti-β-actin (Cell Signaling Technology). Then, membranes were incubated for 1 h with HRP-conjugated anti-rabbit IgG antibody (Cell Signaling Technology). Then, the blots were developed using the ECL system (GE Healthcare, Little Chalfont, UK) and band density was quantified by Image J software (Image Processing and Analysis in Java, National Institutes of Health, Bethesda, MD, USA) and normalized to β-actin.
Liver tissue from each group was fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100 in PBS for 15 min at room temperature. Unspecific binding sites were blocked with 2% BSA for 30 min at 4 °C. Slides were stained with rabbit anti-phospho-AKT (Bioworld). After staining, slides were washed with PBS and Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody (1:1000 dilution) was added. Finally, samples were washed then analyzed under a microscope by using AxioVision Rel 4.7 (Carl Zeiss GmbH, Jena, Germany). Quantification of fluorescence was achieved by using Image-ProPlus software v.6.0 (Media Cybernetics, Silver Spring, MD, USA).
Measurements of glucose levels
A total of 1 × 106 RAW264.7 cells were seeded into 12-well plates and the medium was changed after 6 h. Cells were stimulated with SEA (25 μg/ml) with or without the inhibitors of p-AMPK (dorsomorphin, MEC, 10 μmol), p-AKT (dihydrochloride, 10 μmol) or p-mTOR (rapamycin, 5 μmol) for 24 h, then the culture medium was collected for measurement of glucose concentrations. Glucose levels were determined using a Glucose assay kit (Sigma-Aldrich, St. Louis, MO, USA).
Oil red O staining
Intracellular lipid accumulation of RAW264.7 cells was determined by oil red O staining. Cells were fixed with 4% formaldehyde for 15 min at room temperature and stained with oil red O solution (0.5% oil red O in isopropyl alcohol/water = 3:2) for 2 h. After staining, the cells were washed three times with water to remove excess stain. The quantification of intracellular lipid by oil red O staining (lipid droplets positive cells vs the cell section area) was performed using Image J software.
A total of 1 × 106 RAW264.7 cells were separated into 12-well plates and stimulated with SEA (25 μg/ml) for 24 h at 37 °C. Then, unstimulated FL83b cells (1 × 106) were seeded in the lower chamber of the transwell, and the SEA-activated RAW264.7 cells (1 × 106) were added into the upper chamber and co-cultured for another 24 h. After that, the FL83b cells were collected in the lower chamber and the expression of metabolic genes using real-time PCR was analyzed.
All analyses were carried out with SPSS v.19.0 software. Data are shown as the mean ± standard deviation (SD). The significance of the difference between two groups was identified using Student’s t-test. Multiple comparisons were performed by one-way ANOVA and followed by LSD post-hoc test for comparison between every two groups. P-values < 0.05 were considered significant. Graphs were generated using the software GraphPad Prism v.7.0.
Expression profiling of hepatic genes associated with glucose metabolism during Schistosoma japonicum infection
Our previous study showed that the whole-body and hepatic insulin sensitivity were decreased in S. japonicum-infected mice . In consistence with this, the level of fasting blood glucose in mice was significantly decreased after S. japonicum infection (Fig. 1a; two-way ANOVA; F(1, 5) = 11.68, P = 0.0066). To investigate the specific glucose metabolism-related genes involved in this process, we profiled the dynamic mRNA expression of glucose metabolic genes in the livers of S. japonicum infected mice. As shown in Fig. 1b, the kinetics of glycolysis-related genes expression (Ldha, Glut4, Pkm2, Glut1, Pfkfb3, Aldoc, Hk2, Pfk) (ANOVA and LSD multiple comparison test; Ldha: F(3, 23) = 6.511, P = 0.0030; Glut4: F(3, 23) = 6.276, P = 0.0035; Pkm2: F(3, 23) = 65.51, P < 0.0001; Glut1: F(3, 23) = 22.53, P < 0.0001; Pfkfb3: F(3, 23) = 9.281, P = 0.0005; Aldoc: F(3, 23) = 19.09, P < 0.0001; Hk2: F(3, 23) = 34.54, P < 0.0001; Eno3: F(3, 23) = 14.39, P < 0.0001; Pfk: F(3, 23) = 28.85, P < 0.0001) in the liver were upregulated but G6pc, a gluconeogenesis gene, was downregulated after S. japonicum eggs were deposited in the liver (ANOVA and LSD multiple comparison test; G6pc: F(3, 23) = 8.217, P = 0.009). The above genes were not changed in control mice at different time points corresponding to infected mice (Additional file 2: Figure S1; ANOVA and LSD multiple comparison test; pdk1: F(3, 23) = 0.062, P = 0.9790; Ldha: F(3, 23) = 1.375, P = 0.2791; Glut4: F(3, 23) = 0.0796, P = 0.9706; Pkm2: F(3, 23) = 0.373, P = 0.7731; Glut1: F(3, 23) = 0.161, P = 0.9214; Pfkfb3: F(3, 23) = 0.8802, P = 0.4680; Aldoc: F(3, 23) = 0.895, P = 0.4610; G6pc: F(3, 23) = 0.687, P = 0.5706; Hk2: F(3, 23) = 0.183, P = 0.9069; Eno3: F(3, 23) = 1.234, P = 0.3235; Pfk: F(3, 23) = 0.202, P = 0.8940). Since serine/threonine kinase AKT is the key factor that directly influences glucose metabolism , we next detected the level of hepatic phosphorylated AKT (T308) in mice with S. japonicum infection by using immunofluorescence. As expected, the expression of hepatic phosphorylated AKT was significantly enhanced in the liver at 7 and 11 weeks post-infection (Fig. 1c, d). Together, these results indicate that S. japonicum infection promotes metabolic gene expression of hepatic glycolysis, but inhibits gene expression related to glucose synthesis.
Dynamics of hepatic lipid metabolic genes during Schistosoma japonicum infection
Our unpublished data indicated that the serum cholesterol and triglycerides levels in mice were decreased post-S. japonicum-infection. We next assessed the kinetics of lipid metabolism-related genes expression during S. japonicum infection (Fig. 2). Results showed that the hepatic mRNA expression of fatty acid (FA) oxidation-related genes (Ucp2, Atp5b, Pparg) (ANOVA and LSD multiple comparison test; Ucp2: F(3, 23) = 8.761, P = 0.0007; Atp5b: F(3, 23) = 7.939, P = 0.0011; Pparg: F(3, 23) = 20.97, P < 0.0001) in S. japonicum infected mice were significantly upregulated. However, the FA synthesis genes (Fas, Acc, Scd1, Srebp1c) (ANOVA; Fas: F(3, 23) = 37.56, P < 0.0001; Acc: F(3, 23) = 54.63, P < 0.0001; Scd1: F(3, 23) = 19.08, P < 0.0001; Srebp1c: F(3, 23) = 33.57, P < 0.0001) and lipid uptake gene (CD36) (ANOVA and LSD multiple comparison test; CD36: F(3, 23) = 12.10, P < 0.0001) were downregulated after S. japonicum egg deposition (Fig. 2b). These lipid metabolism-related genes were not changed in control mice at the time points corresponding to infected mice (Additional file 3: Figure S2; ANOVA and LSD multiple comparison test; Acox1: F(3, 23) = 1.114, P = 0.3668; cpt1: F(3, 23) = 0.6700, P = 0.5804; Ucp2: F(3, 23) = 0.2035, P = 0.8928; Atp5b: F(3, 23) = 0.2363, P = 0.8700; Pparg: F(3, 23) = 0.9792, P = 0.4223; Fas: F(3, 23) = 0.3470, P = 0.7917; Acc: F(3, 23) = 0.2448, P = 0.8641; Scd1: F(3, 23) = 1.276, P = 0.3096; Srebp1c: F(3, 23) = 0.3687, P = 0.7764; CD36: F(3, 23) = 0.5118, P = 0.6788) (Fig. 2a).
The effects of SEA on macrophage glycolipid metabolism in vitro
Since macrophages have been shown to play important roles in the metabolic functions in the liver , we next investigated whether SEA could induce changes in macrophage energy metabolism in vitro. As shown in Fig. 3a, stimulation with SEA significantly enhanced the gene expression involved in glycolysis (Pdk1, Ldha, Glut4, Pkm2, Aldoc) (t-test; Pdk1: t(4) = 4.387, P = 0.0118; Ldha: t(4) = 3.890, P = 0.0177; Glut4: t(4) = 2.943, P = 0.0423; Pkm2: t(4) = 5.129, P = 0.0068; Glut1: t(4) = 1.979, P = 0.1189; Pfkfb3: t(4) = 2.242, P = 0.0884; Aldoc: t(4) = 9.410, P = 0.0007; HK2: t(4) = 2.775, P = 0.0501; Eno3: t(4) = 2.049, P = 0.1099; Pfk: t(4) = 2.330, P = 0.0803). However, the expression of G6pc mRNA was decreased after SEA stimulation in macrophages (t-test: t(4) = 9.149, P = 0.0008). In addition, stimulation with SEA resulted in upregulation of FA oxidation-related genes in macrophages, as evidenced by significantly increased expression of Acox1, Cpt1 and Ucp2 (Fig. 3b) (t-test; Acox1: t(4) = 5.145, P = 0.0068; Cpt1: t(4) = 3.314, P = 0.0295; Ucp2: t(4) = 3.311, P = 0.0296; Atp5b: t(4) = 1.040, P = 0.3571; Pparg: t(4) = 1.888, P = 0.1320). Furthermore, SEA also inhibited FA synthesis and lipid uptake in macrophages, as evidenced by markedly decreased gene expression of Fas, Acc, Scd1, Srebplc and Cd36 (Fig. 3b) (t-test; Fas: t(4) = 3.294, P = 0.0301; Acc: t(4) = 5.360, P = 0.0058; Scd1: t(4) = 9.452, P = 0.0007; Srebpl: t(4) = 16.98, P < 0.0001; Cd36: t(4) = 7.190, P = 0.0020). A previous study showed that the oxidative metabolism in macrophages provided the energy for M2 macrophages polarization . Consistently, SEA treated macrophages showed a M2-dominant phenotype, as evidenced by increased expression of IL-13, IL-10 and IL-4 (t-test; IL-13: t(4) = 4.658, P = 0.0096; IL-10: t(4) = 3.494, P = 0.0250; IL-4: t(4) = 4.372, P = 0.0120), but not TNF-α and IL-12 (t-test; TNF-α: t(4) = 1.952, P = 0.1084; IL-12: t(4) = 1.037, P = 0.358) (Fig. 3c).
Activation of metabolic sensors by SEA on macrophages
To understand the molecular mechanisms behind the observed phenotype, we next stimulated macrophages with SEA in vitro. Results obtained show that SEA stimulation is associated with a comparable increase in the level of phosphorylated AMPK (Thr172) but no change in total AMPK abundance in macrophages (Fig. 4a). In addition, a similar increase in the level of phosphorylated AKT (T308) was noted in macrophages after SEA stimulation. Furthermore, mTORC1, which plays an important role in controlling the stability between anabolism and catabolism , was also enhanced in the phosphorylated (S2448) form but not total protein level in macrophages with SEA stimulation. However, there were no significant differences with respect to phosphorylated PI3K (Y467/Y199) or total abundance between SEA-treated and control group in this cell line (Fig. 4a).
To further clarify the roles of phosphorylated-AMPK, phosphorylated-AKT and phosphorylated-mTOR pathways on glycolipid metabolism under SEA stimulation, we used the inhibitors of phosphorylated-AMPK, phosphorylated-AKT and phosphorylated-mTORC1 to treat PBS/SEA-stimulated macrophages. Results showed that SEA stimulation decreased the glucose levels in macrophages, while suppression of phosphorylated-AMPK (Additional file 4: Figure S3a), phosphorylated-AKT (Additional file 4: Figure S3b) and phosphorylated-mTORC1 (Additional file 4: Figure S3c) in SEA-stimulated macrophages could increase glucose levels (Fig. 4b) (ANOVA and LSD multiple comparison test: F(3, 11) = 85.96, P < 0.0001; F(3, 11) = 51.71, P < 0.0001; F(3, 11) = 211.3, P < 0.0001). In addition, SEA-stimulated macrophages showed a significant decrease in the lipid levels, while suppression of phosphorylated-AMPK, but not phosphorylated-AKT and phosphorylated-mTORC1, promoted lipid accumulation in macrophages (Fig. 4c, Additional file 4: Figure S3d) (ANOVA and LSD multiple comparison test: F(7, 79) = 7.813, P < 0.0001).
The effects of macrophages on hepatocytes glycolipid metabolism in vitro
Given that hepatocytes play a critical role in metabolic conversions underlying diverse physiological or pathological functions , we further examined the role of SEA-activated macrophages on hepatocytes metabolism. Results showed that SEA-stimulated macrophages, which showed a M2-dominant phenotype (Fig. 3c), significantly reduced the expression of Acc mRNA in hepatocytes (t-test; Acc: t(4) = 6.869, P = 0.0024) (Fig. 5a); however, the SEA-activated macrophages (M2) did not affect the expression of other genes that related to metabolism in hepatocytes (t-test; Pkm2: t(4) = 0.5789, P = 0.5937; Pfkfb3: t(4) = 0.3680, P = 0.7315; Cpt1: t(4) = 1.606, P = 0.1836) (Fig. 5b–d). Together, our results suggest that the egg antigens-activated macrophages may participate in the regulation of hepatocytes lipid metabolic gene expression.
Schistosome infection can lead to strong natural type 2 immune responses, and epidemiological studies have revealed that schistosome infections inversely correlate with metabolic syndrome [1, 2]. Indeed, animal studies further confirmed that chronic S. mansoni infection or injection with SEA improved insulin sensitivity and reduced fat mass in high diet-induced obese mice . Another metabolic consequence of schistosome infection is the disturbance of glycolysis, which is characterized by significant decreases in plasma and liver glucose and glycogen, as well as the accumulation of liver lactate and urinary pyruvate [20, 21]. However, the signaling pathways that are potentially involved in the energy metabolism during schistosome infection remain unclear, and the metabolism-related gene changes that take place in the liver have not yet been characterized at the cellular level.
We previously reported that chronic exposure to S. japonicum induces a type 2 immune response in the liver and improved insulin sensitivity and glucose tolerance . Here, we have further performed in-depth metabolic profiling, which showed that S. japonicum infection specifically promoted glycolysis-related gene expression, but reduced the expression of genes related to glucose synthesis in the livers of S. japonicum-infected mice. In support of these results, we also found that the level of phosphorylated of AKT, which was reported to be sufficient to accelerate glycolytic cell growth and improve metabolic parameters , was upregulated in the liver of mice infected with S. japonicum. These results suggested that S. japonicum eggs deposited in the liver can directly influence glucose metabolism. Interestingly, there was a striking change in glycolysis-related gene expression at 7 and 11 weeks post-infection. The reason for this may be derived from the egg production after the worm copulation 4 weeks post-infection , which peaks at 6–8 weeks post-schistosome-infection and persists in the liver for a long time . In consistency with these observations, our in vitro data showed similar results, as evidenced by the increase in gene expression involved in glycolysis in SEA-stimulated macrophages.
Previous animal and proteomic studies showed the marked suppression of lipoproteins in the plasma of S. japonicum-infected mice [20, 25]. One explanation is that host phospholipids and triacylglycerols are taken up by adult schistosomes . Another possibility is the impaired intestinal lipid absorption during schistosome infection . However, our data regarding changes in the expression of genes related to fatty acid oxidation and fatty acid synthesis, as well as lipid uptake in our experimental conditions, specifically after egg production, which led us to speculate that the decreased lipoproteins in S. japonicum-infected mice may be partially due to abnormal lipid metabolism efficiency in the liver, which needed further study to confirm.
We further explored the potential metabolic pathways involved in the infection process. AMPK is a key cellular sensor for energy homeostasis by regulating the metabolism of glucose and lipids by promoting glycolysis and fatty acid oxidation and limiting fatty acid synthesis . As an important regulator in glucose metabolism, AKT had been reported to promote glycolysis through increasing GLUT1 trafficking to the cell surface, which is involved in phosphofructokinase (PFK) and hexokinase (HK) activation . Additionally, mTORC1 plays an integral part in regulating anabolism and catabolism, as defects in mTORC1 regulation results in a variety of human diseases, including type 2 diabetes . Our in vitro data showed that S. japonicum egg antigen may exert a strong metabolic pathway effect related to AMPK, AKT and mTORC1 signaling activation in macrophage. Interestingly, by using the phosphorylated inhibitors to AMPK, AKT and mTORC1, we found that all of these signaling molecules contributed to the egg antigen-regulated glucose metabolism in macrophages. However, only the AMPK signaling molecule was found to be necessary for lipid metabolism in SEA-stimulated macrophages.
The interplay between macrophages and hepatocytes in the liver microenvironment may provide new insights into understanding the mechanism of metabolism changes . During S. japonicum infection, macrophages were reported to typically shift from the M1 towards the M2 phenotype , and this process may be related to the expression of scavenger receptor-A or PPAR-γ [33, 34]. Notably, liver macrophages play a critical role in promoting lipid storage through regulating the oxidation of fatty acids in hepatocytes [35, 36], which may be related to PPARδ signaling in macrophages . Our results indicate that SEA-treated macrophages, which are characterized by the M2 phenotype, play a potential role in the reduction of the fatty acid synthesis related gene (Acc) in hepatocytes.
This study identified the dynamic metabolic gene expression in the liver during S. japonicum infection and illustrated egg antigen-induced cellular metabolic response through AMPK, AKT and mTORC1 signaling. Our results highlight the macrophage as a new direction for understanding aberrant glycolipid metabolism during schistosome infection.
Availability of data and materials
The data that support the findings of this study are included within the article and its additional files.
phosphatidyl inositol 3 kinase
mammalian target of rapamycin
protein kinase B
AMP-activated protein kinase
3-phosphoinositide-dependent protein kinase 1
lactate dehydrogenase A
pyruvate kinase muscle isozyme
glucose-6-phosphatase catalytic subunit
acyl-CoA oxidase 1
carnitine palmitoyltransferase 1
uncoupling protein 2
ATP synthase subunit-β
peroxisome proliferator activated receptor gamma
fatty acid synthase
stearoyl-CoA desaturase 1
sterol regulatory element binding protein 1c
fructose-bisphosphate aldolase C
Chen Y, Lu J, Huang Y, Wang T, Xu Y, Xu M, et al. Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China. J Clin Endocrinol Metab. 2013;98:E283–7.
Wiria AE, Sartono E, Supali T, Yazdanbakhsh M. Helminth infections, type-2 immune response, and metabolic syndrome. PLoS Pathog. 2014;10:e1004140.
Shen SW, Lu Y, Li F, Shen ZH, Xu M, Yao WF, et al. The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese men. Parasite Immunol. 2015;37:333–9.
Cooke A, Tonks P, Jones FM, O’Shea H, Hutchings P, Fulford AJ, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999;21:169–76.
Luo X, Zhu Y, Liu R, Song J, Zhang F, Zhang W, et al. Praziquantel treatment after Schistosoma japonicum infection maintains hepatic insulin sensitivity and improves glucose metabolism in mice. Parasites Vectors. 2017;10:453.
Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56:952–64.
Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2:499–511.
Barron L, Wynn TA. Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur J Immunol. 2011;41:2509–14.
Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, O’Brien W, et al. Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol. 2010;184:6438–46.
Nguyen-Lefebvre AT, Horuzsko A. Kupffer cell metabolism and function. J Enzymol Metab. 2015;1:101.
Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Investig. 2007;117:175–84.
Hussaarts L, Garcia-Tardon N, van Beek L, Heemskerk MM, Haeberlein S, van der Zon GC, et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB J. 2015;29:3027–39.
Huh JH, Kim HM, Lee ES, Kwon MH, Lee BR, Ko HJ, et al. Dual CCR13/5 antagonist attenuates obesity-induced insulin resistance by regulating macrophage recruitment and M1/M2 status. Obesity. 2018;26:378–86.
Wang YH, Peng HJ, Gu JB. Improved preparation of pure alive eggs of Schistosoma japonicum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008;26:160–1.
Robey RB, Hay N. Is Akt the “Warburg kinase”?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009;19:25–31.
Jager J, Aparicio-Vergara M, Aouadi M. Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells. J Intern Med. 2016;280:209–20.
Galvan-Pena S, O’Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol. 2014;5:420.
Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960–76.
Sasse D, Spornitz UM, Maly IP. Liver architecture. Enzyme. 1992;46:8–32.
Wu J, Xu W, Ming Z, Dong H, Tang H, Wang Y. Metabolic changes reveal the development of schistosomiasis in mice. PLoS Negl Trop Dis. 2010;4:e807.
Wang Y, Holmes E, Nicholson JK, Cloarec O, Chollet J, Tanner M, et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci USA. 2004;101:12676–81.
Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, et al. Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 2008;7:159–72.
Walker AJ. Insights into the functional biology of schistosomes. Parasites Vectors. 2011;4:203.
Giver H, de Vlas SJ, Johansen MV, Christensen NO, Nansen P. Schistosoma japonicum: day to day variation in excretion and hatchability of parasite eggs in the domestic pig, Suis suis. Exp Parasitol. 2000;95:8–18.
Liu F, Hu W, Cui SJ, Chi M, Fang CY, Wang ZQ, et al. Insight into the host–parasite interplay by proteomic study of host proteins copurified with the human parasite, Schistosoma japonicum. Proteomics. 2007;7:450–62.
Allan D, Payares G, Evans WH. The phospholipid and fatty acid composition of Schistosoma mansoni and of its purified tegumental membranes. Mol Biochem Parasitol. 1987;23:123–8.
Ferreira HS, Coutinho EM, Teodosio NR, Cavalcanti CL, Samico Mde J. Intestinal protein absorption in malnourished mice with acute schistosomiasis mansoni. Mem Inst Oswaldo Cruz. 1993;88:581–7.
Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16:79.
Coloff JL, Mason EF, Altman BJ, Gerriets VA, Liu T, Nichols AN, et al. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem. 2011;286:5921–33.
Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab. 2011;22:94–102.
Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001;161:1–151.
Zhu J, Xu Z, Chen X, Zhou S, Zhang W, Chi Y, et al. Parasitic antigens alter macrophage polarization during Schistosoma japonicum infection in mice. Parasites Vectors. 2014;7:122.
Xu Z, Xu L, Li W, Jin X, Song X, Chen X, et al. Innate scavenger receptor-A regulates adaptive T helper cell responses to pathogen infection. Nat Commun. 2017;8:16035.
Zhu Y, Ni Y, Liu R, Hou M, Yang B, Song J, et al. PPAR-gamma agonist alleviates liver and spleen pathology via inducing Treg cells during Schistosoma japonicum infection. J Immunol Res. 2018;2018:6398078.
Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219–46.
Neyrinck AM, Taper HS, Gevers V, Declerck B, Delzenne NM. Inhibition of Kupffer cell activity induces hepatic triglyceride synthesis in fasted rats, independent of lipopolysaccharide challenge. J Hepatol. 2002;36:466–73.
Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008;7:496–507.
This work was supported by the grants from the National Natural Science Foundation of China (NSFC) (Project nos. 81702023, 81772222 and 81572025), the National Natural Science Foundation of Jiangsu Province (BK20171049), and the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (17KJB310003). The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.
Ethics approval and consent to participate
The study protocol was reviewed and approved by were approved by Nanjing Medical University Animal Ethics Committee (no. IACUC-1812001). All authors of this paper are authorized to design and perform the experiments with animals. Consent to participate is not applicable.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.